Author

E. Helmy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. R. Pico· 1 shared C. M. Spencer· 1 shared E. G. Sozmen· 1 shared J. K. Ryu· 1 shared K. Akassoglou· 1 shared K. Dixit· 1 shared K. L. Lynch· 1 shared M. H. Ellisman· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. R. Pico

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy

J. K. Ryu, E. G. Sozmen, K. Dixit, M. Montano, Y. Matsui, Y. Liu, E. Helmy, T. J. Deerinck, Z. Yan, R. Schuck, R. M. Acevedo, C. M. Spencer, R. Thomas, A. R. Pico, S. S. Zamvil, , K. Akassoglou

This study shows SARS-CoV-2 Spike protein causes abnormal blood clots and thromboinflammation, which are neutralized by a fibrin-targeting antibody.

bioRxiv · Oct 12, 2021 · PreprintImmunology